Clinical Trials · NCT06411210
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Yale University
- Enrollment
- 54
- Start date
- Jul 2024
- Locations
- 1 site, United States
- Primary endpoint
- Change in VAT/(VAT+SAT) from baseline to 12 months